100 related articles for article (PubMed ID: 11877677)
1. The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma.
Sandler A; Scott D; Azuhata T; Takamizawa S; O'Dorisio S
J Pediatr Surg; 2002 Mar; 37(3):507-11. PubMed ID: 11877677
[TBL] [Abstract][Full Text] [Related]
2. The survivin:fas ratio in pediatric renal tumors.
Takamizawa S; Scott D; Wen J; Grundy P; Bishop W; Kimura K; Sandler A
J Pediatr Surg; 2001 Jan; 36(1):37-42. PubMed ID: 11150435
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract][Full Text] [Related]
4. Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.
Azuhata T; Scott D; Griffith TS; Miller M; Sandler AD
J Pediatr Surg; 2006 Aug; 41(8):1431-40. PubMed ID: 16863850
[TBL] [Abstract][Full Text] [Related]
5. Significance of survivin mRNA expression in prognosis of neuroblastoma.
Ito R; Asami S; Motohashi S; Ootsuka S; Yamaguchi Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2005 Apr; 28(4):565-8. PubMed ID: 15802787
[TBL] [Abstract][Full Text] [Related]
6. Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group.
Miller MA; Ohashi K; Zhu X; McGrady P; London WB; Hogarty M; Sandler AD
J Pediatr Hematol Oncol; 2006 Jul; 28(7):412-7. PubMed ID: 16825985
[TBL] [Abstract][Full Text] [Related]
7. Survivin expression in juvenile-onset recurrent respiratory papillomatosis.
Poetker DM; Sandler AD; Scott DL; Smith RJ; Bauman NM
Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):957-61. PubMed ID: 12450166
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression predicts early recurrence in early-stage breast cancer.
Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing.
Takamizawa S; Okamoto S; Wen J; Bishop W; Kimura K; Sandler A
J Pediatr Surg; 2000 Feb; 35(2):375-9. PubMed ID: 10693700
[TBL] [Abstract][Full Text] [Related]
10. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors.
Tajiri T; Tanaka S; Higashi M; Kinoshita Y; Takahashi Y; Tatsuta K; Suita S
J Pediatr Surg; 2006 Mar; 41(3):560-6. PubMed ID: 16516635
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors.
Miller MA; Karacay B; Breslow NE; Li S; O'Dorisio MS; Grundy PE; Sandler AD
J Pediatr Hematol Oncol; 2005 Jan; 27(1):11-4. PubMed ID: 15654272
[TBL] [Abstract][Full Text] [Related]
13. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.
Schultz IJ; Kiemeney LA; Witjes JA; Schalken JA; Willems JL; Swinkels DW; de Kok JB
Anticancer Res; 2003; 23(4):3327-31. PubMed ID: 12926071
[TBL] [Abstract][Full Text] [Related]
14. [Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence].
Sela B
Harefuah; 2002 Jan; 141(1):103-7, 123. PubMed ID: 11851094
[TBL] [Abstract][Full Text] [Related]
15. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma.
Sarela AI; Macadam RC; Farmery SM; Markham AF; Guillou PJ
Gut; 2000 May; 46(5):645-50. PubMed ID: 10764707
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
[TBL] [Abstract][Full Text] [Related]
17. Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
Chakravarti A; Noll E; Black PM; Finkelstein DF; Finkelstein DM; Dyson NJ; Loeffler JS
J Clin Oncol; 2002 Feb; 20(4):1063-8. PubMed ID: 11844831
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.
Conway EM; Pollefeyt S; Steiner-Mosonyi M; Luo W; Devriese A; Lupu F; Bono F; Leducq N; Dol F; Schaeffer P; Collen D; Herbert JM
Gastroenterology; 2002 Aug; 123(2):619-31. PubMed ID: 12145814
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
[TBL] [Abstract][Full Text] [Related]
20. Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.
Ganas V; Kalaitzis C; Sountoulides P; Giannakopoulos S; Touloupidis S
Minerva Urol Nefrol; 2012 Dec; 64(4):279-85. PubMed ID: 23288215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
